KH801
/ Chengdu Kanghong Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 07, 2024
Phase 1 Trial of KH801
(clinicaltrials.gov)
- P1 | N=17 | Not yet recruiting | Sponsor: Beijing Kanghong Biopharmaceutical Co., Ltd. | Initiation date: May 2024 ➔ Sep 2024
Metastases • Trial initiation date • Oncology • Solid Tumor
April 15, 2024
Phase 1 Trial of KH801
(clinicaltrials.gov)
- P1 | N=17 | Not yet recruiting | Sponsor: Beijing Kanghong Biopharmaceutical Co., Ltd.
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1